文献速递脑血管病神经重症与神经感染

不明起病时间脑出血的血肿扩大研究

Hematoma Expansion in Intracerebral Hemorrhage With Unclear Onset.
PubMed 文献 · Neurology · 2021-04-01

该研究回顾性分析了美国和意大利5个学术医疗中心的原发性自发性脑出血患者,发现不明起病时间(USO)患者血肿扩大(HE)频率与明确起病时间患者相似,且HE与30天死亡率独立相关,NCCT低密度灶是USO患者HE的独立预测因素。

要点

  • USO患者血肿扩大频率与明确起病时间患者相似。
  • USO患者中血肿扩大与30天死亡率独立相关。
  • NCCT低密度灶可独立预测USO患者血肿扩大。

核心结论

  • USO患者血肿扩大常见且与不良预后独立相关,提示USO患者可纳入针对血肿扩大的临床试验。

研究设计与样本

  • 回顾性分析美国与意大利5个学术医疗中心收治的原发性自发性脑出血患者,共2165例,开发队列1022例,验证队列1143例。

主要发现

  • 开发队列中USO患者352例(34.4%),验证队列中407例(35.6%)。
  • USO与明确起病时间患者血肿扩大频率相似:开发队列25.0% vs 21.9%(p=0.269),验证队列29.9% vs 31.5%(p=0.423)。
  • USO患者中血肿扩大与死亡率独立相关:开发队列OR 2.64(95%CI 1.43-4.89,p=0.002),验证队列OR 3.46(95%CI 1.86-6.44,p<0.001)。
  • USO患者NCCT低密度灶预测血肿扩大:开发队列OR 2.59(95%CI 1.27-5.28,p=0.009),验证队列OR 2.43(95%CI 1.42-4.17,p=0.001)。

关键数值与推荐

  • 血肿扩大定义为基线至随访NCCT体积增加>6 mL或>33%。

临床怎么用

  • 对USO脑出血患者应评估血肿扩大风险,NCCT低密度灶可辅助识别高风险患者。
  • USO患者可考虑纳入针对血肿扩大的临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prevalence, predictors, and prognostic effect of hematoma expansion (HE) in patients with intracerebral hemorrhage (ICH) with unclear symptom onset (USO). METHODS: We performed a retrospective analysis of patients with primary spontaneous ICH admitted at 5 academic medical centers in the United States and Italy. HE (volume increase >6 mL or >33% from baseline to follow-up noncontrast CT [NCCT]) and mortality at 30 days were the outcomes of interest. Baseline NCCT was also analyzed for presence of hypodensities (any hypodense region within the hematoma margins). Predictors of HE and mortality were explored with multivariable logistic regression. RESULTS: We enrolled 2,165 participants, 1,022 in the development cohort and 1,143 in the replication cohort, of whom 352 (34.4%) and 407 (35.6%) had ICH with USO, respectively. When compared with participants having a clear symptom onset, patients with USO had a similar frequency of HE (25.0% vs 21.9%, p = 0.269 and 29.9% vs 31.5%, p = 0.423). Among patients with USO, HE was independently associated with mortality after adjustment for confounders (odds ratio [OR] 2.64, 95% confidence interval [CI] 1.43-4.89, p = 0.002). This finding was similar in the replication cohort (OR 3.46, 95% CI 1.86-6.44, p < 0.001). The presence of NCCT hypodensities in patients with USO was an independent predictor of HE in the development (OR 2.59, 95% CI 1.27-5.28, p = 0.009) and replication (OR 2.43, 95% CI 1.42-4.17, p = 0.001) population. CONCLUSION: HE is common in patients with USO and independently associated with worse outcome. These findings suggest that patients with USO may be enrolled in clinical trials of medical treatments targeting HE.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Morotti A, Boulouis G, Charidimou A, et al. Hematoma Expansion in Intracerebral Hemorrhage With Unclear Onset. Neurology. 2021. PMID: 33795389. doi:10.1212/WNL.0000000000011895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。